跳至主要内容
临床试验/NCT06397885
NCT06397885进行中(未招募)不适用

Prospective on Market Patient-reported Outcomes for Milli

Materna Medical1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200
试验地点
1
主要终点
Penetration Efficiency Questionnaire

研究概览

简要总结

To assess the effectiveness of the Milli device in achieving vaginal intercourse

详细描述

The Milli Vaginal Dilator is a patient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion.

This study is intended to provide data in support of the Milli Vaginal Dilator as a commercially available, over-the-counter medical device.

The Milli has been granted marketing authorization by the FDA under premarket notification K220035 for the following Indications for Use statement:

The Milli Vaginal Dilator is a tool indicated for controlled dilation of the vagina. It can be used for dilation for an examination (by your doctor), in preparation for a surgical procedure, or to help relieve the symptoms of vaginismus (condition that involves tightening of the vaginal muscles) and related painful sex.

.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is a female at birth aged ≥18 years of age
  • Subject is able to read and understand the approved, informed consent form (ICF)
  • Subject meets vaginismus and related painful sex/GPPPD criteria as defined in the DSM-5, as confirmed by having one or more of the following for greater than 6 months:
  • Pelvic pain
  • Vaginal pain
  • Pain with vaginal intercourse
  • Pain with vaginal penetration
  • Fear or anxiety about vaginal or pelvic pain with vaginal penetration
  • The inability to achieve vaginal penetration
  • Subject currently has a sexual partner with a functional penis
  • Subject is currently seeking vaginal penetration to achieve sexual intercourse
  • Subject is currently unable to tolerate vaginal penetration to achieve sexual intercourse (Score of ≤1 on PEQ Question #1)
  • Subject purchased Milli vaginal dilator
  • Subject is not contraindicated for Milli vaginal dilator use
  • Subject is able and willing to comply with study protocol

排除标准

  • Subject has previously participated in any studies by the company in the past 12 months or has used Milli prior to enrollment
  • Subject is pregnant
  • Subject has an active pelvic infection (vagina or vulva)
  • Subject has open wounds in the tissue inside or surrounding the vagina
  • Subject has an untreated major mental health disorder (e.g., affective disorder, psychosis, PTSD)
  • Subject has prior history of gender-confirming surgery, vaginal reconstruction surgery, pelvic radiation, and/or vaginal procedures that result in extensive scarring (with the exception of hysterectomy procedures)
  • Subject or subject's partner experiences other conditions preventing intercourse (e.g., erectile dysfunction, lack of libido)

结局指标

主要结局

Penetration Efficiency Questionnaire

时间窗: 6 months

Ability to achieve full vaginal penetration with the penis of the partner (intercourse) as measured by the Penetration Efficiency Questionnaire (Score of ≥2 on PEQ Question #1) at six months

次要结局

  • Penetration Efficiency Questionnaire(3 months, 6 months)
  • Female Sexual Function Index (FSFI)(3 months, 6 months)
  • Numerical Rating Scale(3 months, 6 months)

研究者

发起方
Materna Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验